Point of Care Testing Market - Global Forecast 2025-2032

Point of care testing is redefining how healthcare providers access real-time diagnostic data, supporting agile clinical decisions directly at the patient site. As decentralized and data-driven care models shape industry conversations, decision-makers are leveraging point of care testing to drive operational efficiencies and improved patient outcomes.

Market Snapshot: Point of Care Testing Market Size and Growth

The Point of Care Testing Market expanded from USD 32.87 billion in 2024 to USD 37.13 billion in 2025, with a steady compound annual growth rate (CAGR) of 13.53% forecast through 2032, ultimately reaching USD 90.76 billion. Advancements in diagnostic platforms and transitioning care settings are propelling this robust upward trend. Decision-makers are responding to the evolving healthcare landscape by investing in these technologies, driving new partnerships, and pursuing competitive advantages that strengthen diagnostics accessibility and performance.

Scope & Segmentation

This report delivers an in-depth view of all core segments and their relevance for strategic planning. Coverage supports executive-level decisions by outlining the diversity of product types, applications, and technologies accelerating the adoption of point of care solutions globally.

• Product Categories: Consumables & Accessories, Service, Maintenance & Calibration, Software & Connectivity, Benchtop Analyzers, Molecular Platforms, Portable Analyzers, Readers & Scanners, Glucose Test Strips, Hematology Reagents, Immunoassay Reagents, Lateral Flow Assay Reagents, Molecular Assay Kits
• Test Types: Blood Gases, Cardiac Markers including B-type Natriuretic Peptide and Troponin, Comprehensive Metabolic Panel, Drug Of Abuse Testing, Coagulation Tests such as Activated Partial Thromboplastin Time, Fibrinogen Level, Prothrombin Time & International Normalized Ratio, Complete Blood Count, Gastrointestinal and Respiratory Infection Tests, Sexually Transmitted Infection Tests, Molecular Diagnostics, Pregnancy & Fertility, Urinalysis
• Sample Types: Blood, Nasal & Swab Samples, Saliva, Urine
• Technology Platforms: Biosensor Electrochemical, Colorimetric Platforms, Immunoassay, Lateral Flow Assays (including Antibody, Antigen, Multiplex Lateral Flow), Microfluidics, PCR and Molecular
• Portability: Benchtop Fixed Analyzers, Portable Handheld Devices
• Mode of Purchase: Over-The-Counter Tests, Prescription-Based Tests
• Applications: Chronic Disease Management, Emergency and Critical Care, Infectious Disease Diagnosis, Occupational and Workplace Testing, Oncology Monitoring, Women Health
• End Users: Ambulatory Care Centers, Diagnostic Laboratories, Free-Standing Emergency Departments, Home Care, Hospitals & Clinics, Urgent Care Centers
• Distribution Channels: Direct Sales, Distributor & Wholesale, Retail & Pharmacy, Online
• Geographies Covered: Americas including United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru; Europe, Middle East & Africa with markets such as UK, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya; Asia-Pacific regions such as China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan
• Company Coverage: Analysis includes key innovators such as F. Hoffmann-La Roche Ltd, Abbott Laboratories, EKF Diagnostics Holdings, Medtronic Plc, Siemens Healthineers AG, along with other global leaders

Key Takeaways for Point of Care Testing Strategies

• Biosensor, microfluidic, and lateral flow immunoassay convergence continues to simplify workflow and enable faster, more precise diagnostics, particularly in decentralized and remote care environments.
• Adoption of integrated digital solutions is improving electronic health record connectivity, promoting predictive and preventive care models while enhancing efficiency for healthcare staff.
• Telehealth integration and remote monitoring support the shift toward patient-centric care, enhancing engagement and enabling real-time management of chronic and acute conditions.
• Regulatory harmonization and adaptive compliance frameworks encourage technology innovation and assurance of quality standards for new platforms and testing solutions.
• Multi-party collaboration across established manufacturers, mid-scale innovators, and digital health startups is accelerating market validation, prompting greater adoption of next-generation diagnostic tools.
• Focus on local manufacturing and diversified suppliers is addressing supply chain resilience, supporting cost management and sustained access to critical diagnostic components.

Tariff Impact

The upcoming 2025 tariffs on diagnostic reagents and components in the United States are increasing operational challenges for point of care testing suppliers. Executives are responding with advanced sourcing strategies, domestic production expansions, and leveraging government incentives to stabilize supply chains and offset rising costs.

Methodology & Data Sources

The research methodology combines secondary analysis of academic works, patents, industry white papers, and regulatory updates with executive and clinician interviews. All insights are validated through expert panels and comprehensive data triangulation for reliability and actionable guidance.

Why This Report Matters

• Supports senior executives in seizing growth opportunities and anticipating major shifts in diagnostic supply chains for informed decision-making.
• Delivers actionable segmentation insights aligned with regulatory change, technology evolution, and shifting patient care models essential for robust planning.
• Guides investment focus by outlining value drivers and collaborative developments across global healthcare regions.

Conclusion

Point of care testing is reshaping diagnostic processes and care delivery models. Organizations leveraging integrated technologies and resilient supply approaches will be well positioned as the market continues to expand and evolve.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.